{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Return to msk.org
Memorial Sloan Kettering Cancer Center
  • Sign In
  • Live Courses
  • On Demand eLearning
  • Coming Soon
  • Visiting Us
  • About
  • Resources & Policies
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

Select a button below to sign in or create an account. If you have previously registered or attended a MSK CME event, please sign in using the username and password created at course registration. MSK employees must use their SSO credentials to sign in. 

Single Sign On (MSK Employees)
Sign in or Create an Account
Enter your email and password to login:

*
*
Login

New to Memorial Sloan Kettering Cancer Center? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • ACHPN
  • ACNP
  • ACNP-BC
  • AGACNP
  • AGACNP-BC
  • AGCNS
  • AGNP
  • AGNP-BC
  • ANP
  • ANP-BC
  • AS
  • AT
  • AuD
  • BA
  • BAO
  • BCC
  • BCh
  • Bchir
  • BM
  • BS
  • BS, MS
  • BSN
  • BSN, MS
  • BSN, MS, DNP
  • CCC-SLP
  • CCLS
  • CCRN
  • CCRP
  • CEN
  • ChB
  • CIPS
  • CNM
  • CNP
  • CPNP
  • CPNP-AC
  • CRNA
  • CRNP
  • CTTS
  • D(ABMM)
  • DAc
  • DACM
  • DAHM
  • DAOM
  • DDS
  • DDS, MPH
  • DMD
  • DMD, PhD
  • DNB
  • DNP
  • DNP, RN
  • DNSc
  • DO
  • DPM
  • DPM
  • DPT
  • DrPH
  • DSc
  • DVM
  • EdD
  • EdS
  • FAAP
  • FACNM
  • FACOG
  • FACS
  • FASCRS
  • FASN
  • FCCM
  • FCCP
  • FIPP
  • FNP
  • FNP-BC
  • GNP
  • GNP-BC
  • HUC
  • JD
  • LAc
  • LCSW
  • LISW
  • LISW-S
  • LMSW
  • LPCC
  • LPN
  • LSW
  • MA
  • MAc
  • MAcOM
  • MB
  • MB, PhD
  • MBA
  • MBBCh
  • MBBCh BAO
  • MBBCh BAO, PhD
  • MBBCh, MPH
  • MBBCh, PhD
  • MBBS
  • MBBS, MPH
  • MBBS, PhD
  • MBChB
  • MD
  • MD, DSc
  • MD, FCCP
  • MD, FCCP, DAABIP
  • MD, JD
  • MD, MA
  • MD, MAS
  • MD, MBA
  • MD, MHA
  • MD, MPH
  • MD, MPH, MHS
  • MD, MS
  • MD, MS, PhD
  • MD, PhD
  • MD, PhD, MA
  • MD, PhD, MPH
  • MD, PhD, MS
  • MDiv
  • MDS
  • MEd
  • MHS
  • MPA
  • MPH
  • MPhil
  • MS
  • MSc
  • MSc, PhD
  • MSN
  • MSPH
  • NCTTP
  • None
  • NP
  • NP, RN
  • OCN
  • OD
  • Other
  • OTR
  • PA
  • PA-C
  • PCA
  • PharmD
  • PharmD, PhD
  • PhD
  • PhD, MBA, MS
  • PhD, MPH
  • PhD, MPhil
  • PhD, MS
  • PhD, MSc
  • PhD, NP, RN
  • PsyD
  • PT
  • RA
  • RCS
  • RD
  • RDCS
  • RDMS
  • RN
  • RN-BC
  • RPh
  • RRT
  • RT
  • ScD
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

2026 Update in Hematology and Medical Oncology


2026 Update in Hematology and Medical Oncology Banner

  • Overview
  • Register
  • Brochure
  • Faculty
Add to Calendar 2026 Update in Hematology and Medical Oncology 3/13/2026 9:10:00 AM 3/16/2026 4:00:00 PM America/New_York For More Details: https://mskcc.cloud-cme.com/course/courseoverview?EID=56570 Description: The Memorial Sloan Kettering Cancer Center 2026 Update in Hematology and Medical Oncology and 14th Annual Board Review is a four-day comprehensive course offering an in-depth, current review of the diagnosis, staging, and management of neoplastic diseases across both solid tumors and hematologic malignancies. Expert-led lectures cover a wide spectrum of disease-specific topics, including gastrointestin... Online false MM/DD/YYYY


Date & Location
Friday, March 13, 2026, 9:10 AM - Monday, March 16, 2026, 4:00 PM, Online

Specialties
Specialties - Hematology, Infectious Diseases, Medical Oncology, Oncology and Hematology, Radiation Oncology, Surgical Oncology

Overview

The Memorial Sloan Kettering Cancer Center 2026 Update in Hematology and Medical Oncology and 14th Annual Board Review is a four-day comprehensive course offering an in-depth, current review of the diagnosis, staging, and management of neoplastic diseases across both solid tumors and hematologic malignancies. Expert-led lectures cover a wide spectrum of disease-specific topics, including gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, in addition to hematologic oncology.

The program will take place live over four days via Zoom. Each lecture will conclude with a live Q&A, allowing ample time for faculty to address participant questions. Participants will receive access to an online syllabus after the course that includes recorded videos of the presentations as well as downloadable PDF versions of the faculty slide decks.

This course is designed for medical oncology professionals — including physicians, nurses, pharmacists, advanced practice providers, fellows, and residents — seeking a comprehensive update in the field as well as those preparing for American Board of Internal Medicine (ABIM) certification and recertification examinations in Medical Oncology and Hematology.


Objectives
  1. Define state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers and hematologic cancers
  2. Discuss recent treatment advances in solid tumor and hematologic oncology and apply knowledge gained in modern clinical practice
  3. Prepare for ABIM examinations in medical oncology and hematology

Registration

This program will be held virtually via Zoom. Detailed access instructions will be provided prior to the start of the program.

Registration Fees

  • Physicians (MDs, PhDs, DOs): $2,000

  • Advanced Practice Providers, Residents, Fellows, Nurses, & Other Healthcare Providers: $1,075

  • Industry Professionals: $3,500*

  • MSK Employees: Complimentary

*An “industry professional” is defined as any individual, irrespective of their provider type (such as MDs, PhDs, APPs, RNs, etc.) that is employed by an ineligible company. Please review our Registration Policy for Industry Professionals for more information.

Registration Discounts: Discounted registration is available for specific groups. If eligible, you will receive further instructions and a promotion code to use during registration. View our policy on Registration Discounts for more information.

Cancellation Policy: For details on our cancellation terms, please review our Cancellation Policy.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 35.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 35.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.



Keywords: ABIM MOCAMA PRA Category 1Virtual

 

Course Directors

David Ilson, MD, PhD
Attending, Member, Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College

Paul Hamlin, MD
Attending, Lymphoma Service
Memorial Sloan Kettering Cancer Center 
Professor of Clinical Medicine, Weill Cornell Medical College

 

Course Faculty

Ghassan Abou-Alfa, MD, JD, MBA
Attending, Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College
Adjunct Professor of Medical Diplomacy, Trinity College Dublin

Carol Aghajanian, MD
Chief, Gynecologic Medical Oncology Service
Avon Chair in Gynecologic Oncology Research
Memorial Sloan Kettering Cancer Center

Kathryn Arbour, MD
Assistant Attending, Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center

P. Dayand Borge, MD, PhD
Chief, Transfusion Medicine and Cell Therapy Service
Memorial Sloan Kettering Cancer Center

Lior Braunstein, MD
Associate Attending, External Beam Radiotherapy Service
Memorial Sloan Kettering Cancer Center

Susanna Curtis, MD 
Assistant Professor of Medicine
Icahn School of Medicine at Mount Sinai
Assistant Director, Adult Sickle Cell Program
Mount Sinai Hospital

Lara Dunn, MD
Assistant Attending, Head and Neck Oncology Service 
Memorial Sloan Kettering Cancer Center

Joshua Drago, MD, MS
Assistant Attending, Breast Medicine Service
Memorial Sloan Kettering Cancer Center

Darren Feldman, MD
Chair, Quality Assurance
Section Head, Germ Cell Cancer
Associate Attending, Genitourinary Oncology Service
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine, Weill Cornell Medical College

Mark Geyer, MD
Program Leader, Adolescent and Young Adult Program and Adult Lymphoblastic Leukemia Program
Assistant Attending, Leukemia Service
Chair, Quality Assessment, Cellular Therapy Service
Memorial Sloan Kettering Cancer Center

Aaron Goldberg, MD, PhD
Assistant Attending, Leukemia Service
Memorial Sloan Kettering Cancer Center

Mrinal Gounder, MD
Physician Ambassador, India and Asia
Associate Attending, Sarcoma Medical Oncology Service and Early Drug Development Service
Memorial Sloan Kettering Cancer Center

Rachel Grisham, MD
Section Head, Ovarian Cancer
Director, Gynecologic Medical Oncology, MSK Westchester
Associate Attending, Gynecologic Medical Oncology Service
Memorial Sloan Kettering Cancer Center

Malin Hultcrantz, MD, PhD
Associate Attending, Myeloma Service
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine, Weill Cornell Medicine

Gopa Iyer, MD
Section Head, Bladder Cancer
Associate Attending, Genitourinary Oncology Service and Early Drug Development Service
Memorial Sloan Kettering Cancer Center

Thomas Kaley, MD
Chief, Neuro-Oncology and Cancer Neurology Service 
Vice Chair, Clinical Research, Department of Neurology
Chair, Institutional Review Board (IRB-C)
Memorial Sloan Kettering Cancer Center

Avi Leader, MD
Assistant Attending, Hematology Service
Memorial Sloan Kettering Cancer Center

Grace Linder, MD
Director, Education Programs
Assistant Director, Transfusion Medicine Service 
Assistant Attending, Department of Pathology and Laboratory Medicine 
Memorial Sloan Kettering Cancer Center

Robert Maki, MD, PhD
Attending, Member, Sarcoma Medical Oncology Service and Early Drug Development Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College

Anita Mamtani, MD, FACS
Surgical Site Director, MSK Bergen
Assistant Attending, Breast Service
Memorial Sloan Kettering Cancer Center

Simon Mantha, MD, MPH
Attending, Hematology Service
Memorial Sloan Kettering Cancer Center

Michael Mauro, MD
Attending, Member, Leukemia Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College

Alison Moskowitz, MD
Associate Attending, Lymphoma Service
Memorial Sloan Kettering Cancer Center

Robert Motzer, MD
Section Head, Kidney Cancer
Jack and Dorothy Byrne Chair in Clinical Oncology
Attending, Genitourinary Oncology Service
Memorial Sloan Kettering Cancer Center

Michael Offin, MD
Co-Director, Mesothelioma Program
Assistant Attending, Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center

Eileen O’Reilly, MD
Winthrop Rockefeller Endowed Chair in Medical Oncology
Chair, Human Research Protection Program and Institutional Review Board
Co-Director, Medical Initiatives, David M. Rubenstein Center for Pancreatic Cancer Research
Section Head, Hepatopancreaticobi
Attending, Member, Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College

Michael Postow, MD
Chief, Melanoma Service
Co-Director, Melanoma Disease Management Team
Memorial Sloan Kettering Cancer Center

Raajit Rampal, MD, PhD
Director, Center for Hematologic Malignancies
Director, Myeloproliferative Neoplasms Program
Associate Attending, Leukemia Service
Memorial Sloan Kettering Cancer Center

Jessica Ross, MD
Assistant Attending, Thoracic Oncology Service and Early Drug Development Service
Memorial Sloan Kettering Cancer Center

Leonard Saltz, MD
Executive Director, Clinical Value and Sustainability 
Head, Colorectal Oncology Section
Attending, Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical Center

Rachel Sanford, MD
Associate Attending, Breast Medicine Service
Memorial Sloan Kettering Cancer Center

Craig Sauter, MD
Medical Director, Regional Network
Attending, Bone Marrow Transplant Service and Cellular Therapy Service
Memorial Sloan Kettering Cancer Center

Susan Seo, MD
Director, Antibiotic Management Program 
Attending, Infectious Disease Service
Memorial Sloan Kettering Cancer Center 
Professor of Clinical Medicine, Weill Cornell Medical College

Gunjan Shah, MD
Assistant Attending, Bone Marrow Transplant Service and Cellular Therapy Service
Memorial Sloan Kettering Cancer Center

Sherry Shen, MD
Assistant Attending, Breast Medicine Service
Memorial Sloan Kettering Cancer Center

Susan Slovin, MD, PhD
Associate Vice Chair, Academic Affairs, Department of Medicine
Attending, Genitourinary Oncology Service and Cellular Therapy Service
Memorial Sloan Kettering Cancer Center

Gerald Soff, MD
Chief, Classical Hematology Service
University of Miami Health System / Sylvester Comprehensive Cancer Center

Zsofia Stadler, MD
Clinical Director, Clinical Genetics Service
Associate Attending, Clinical Genetics Service and Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center

Eytan Stein, MD
Chief, Leukemia Service
Director, Program for Drug Development in Leukemia, Division of Hematologic Malignancies
Memorial Sloan Kettering Cancer Center

Meghan Thompson, MD
Assistant Attending, Leukemia Service
Memorial Sloan Kettering Cancer Center

Anna Varghese, MD
Associate Attending, Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center

Cy Wilkins, MD
Assistant Attending, Hematology Service
Memorial Sloan Kettering Cancer Center
Assistant Professor of Clinical Medicine, Weill Cornell Medical College

Celine Yeh, MD
Assistant Attending, Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center

Andrew Zelenetz, MD, PhD
Medical Director, Quality Informatics
Attending, Lymphoma Service
Memorial Sloan Kettering Cancer Center

Jeffrey Zwicker, MD
Chief, Hematology Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College

 

 

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.

Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Paul A Hamlin, MD
MSK
Activity Co-Director, Faculty
Consulting Fee-AstraZeneca (Relationship has ended)|Consulting Fee-Beigene (Relationship has ended)|Consulting Fee-ADC Therapeutics (Relationship has ended)
David Ilson, MD, PhD
MSK
Activity Director, Faculty
Consulting Fee-Roche|Consulting Fee-Merck and Company, Inc.|Consulting Fee-Bristol-Myers Squibb|Consulting Fee-Daiichi Sankyo|Consulting Fee-Bayer Corporation|Consulting Fee-AstraZeneca|Advisor-Astellas|Advisor-Taiho|Advisor-AMGEN|Advisor-Lilly|Advisor-Oncolys|Advisor-Regeneron
Alice Zervoudakis, MD
MSK
Conflict of Interest Peer Reviewer, Faculty
Nothing to disclose
Ghassan K Abou-Alfa, MD, JD, MBA
MSK
Faculty
Grant or research support-Arcus|Grant or research support-Abbvie|Grant or research support-Agenus|Grant or research support-AstraZeneca|Grant or research support-Atara|Grant or research support-BioNtech|Grant or research support-Bristol-Myers Squibb|Grant or research support-Beigene|Grant or research support-Digestive Care|Grant or research support-Elicio|Grant or research support-Genentech, Inc.|Grant or research support-Helsinn|Grant or research support-Parker Institute|Grant or research support-Pertzye|Grant or research support-Yiviva|Consulting Fee-AstraZeneca|Consulting Fee-Abbvie|Consulting Fee-Ability Pharma|Consulting Fee-Agenus|Consulting Fee-Alligator Biosciences|Consulting Fee-Astellas|Consulting Fee-Arcus|Consulting Fee-Autem|Consulting Fee-Berry Genomics|Consulting Fee-Biontech|Consulting Fee-Celgene|Consulting Fee-Bo|Consulting Fee-Fibrogen|Consulting Fee-Genentech, Inc.|Consulting Fee-J-Pharma|Consulting Fee-Ipsen|Consulting Fee-Merck and Company, Inc.|Consulting Fee-Merus|Consulting Fee-Moma Therapeutics|Consulting Fee-Neogene|Consulting Fee-Novartis AG|Consulting Fee-Regeneron|Consulting Fee-Revolutionary Medicine|Consulting Fee-Servier|Consulting Fee-Syros|Consulting Fee-Tango|Consulting Fee-Vector|Advisor-Tempus|Consulting Fee-Yiviva|Grant or research support-Coherus|Grant or research support-J-Pharma (Relationship has ended)
Carol Aghajanian, MD
MSK
Faculty
Grant or research support-Abbvie (Relationship has ended)|Grant or research support-Genentech, Inc. (Relationship has ended)|Grant or research support-Clovis (Relationship has ended)|Grant or research support-AstraZeneca|Advisor-Merck and Company, Inc. (Relationship has ended)|Advisor-AstraZeneca (Relationship has ended)|Board of Directors Member-GOG Foundation|Board of Directors Member-NRG Oncology|Review Panel Member-WCG
Kathryn C Arbour, MD
MSK
Faculty
Advisor-Revolution Medicines (Relationship has ended)|Advisor-Bristol-Myers Squibb|Advisor-Eli Lilly and Company (Relationship has ended)|Advisor-G1 Therapeutics (Relationship has ended)|Advisor-Regeneron (Relationship has ended)
P. Dayand D Borge Jr., MD, PhD
MSK
Faculty
Lior Braunstein, MD
MSK
Faculty
Nothing to disclose
Susanna Curtis, MD, PhD
Icahn School of Medicine at Mount Sinai
Faculty
Joshua Drago, MD, MS
MSK
Faculty
Advisor-AstraZeneca|Consulting Fee-Revelio Therapeutics (Relationship has ended)|Consulting Fee-Intellisphere LLC (Relationship has ended)|Consulting Fee-Biotheranostics (Relationship has ended)|Consulting Fee-Genagon (Relationship has ended)|Consulting Fee-AmMax Bio (Relationship has ended)|Consulting Fee-NuProbe|Grant or research support-Merck and Company, Inc.
Lara Dunn, MD
MSK
Faculty
Darren Feldman, MD
MSK
Faculty
Mark B Geyer , MD
MSK
Faculty
Grant or research support-Amgen|Consulting Fee-Autolus (Relationship has ended)|Grant or research support-Actinium Pharmaceuticals, Inc|Advisor-Takeda Pharmaceuticals, Inc. (Relationship has ended)|Grant or research support-Tigen
Aaron D Goldberg, MD
MSK
Faculty
Mrinal Gounder, MD
MSK
Faculty
Rachel Grisham, MD
MSK
Faculty
Malin Hultcrantz, MD, PhD
MSK
Faculty
Gopa Iyer, MD
MSK
Faculty
Advisor-Flare Therapeutics|Advisor-Biohaven Pharmaceuticals (Relationship has ended)|Grant or research support-AstraZeneca|Grant or research support-Pfizer, Inc.|Consulting Fee-EMD Serono (Relationship has ended)|Advisor-LOXO Oncology|Honoraria-DAVA Oncology (Relationship has ended)|Advisor-Aadi Biosciences
Thomas Kaley, MD
MSK
Faculty
Avi Leader, MD
MSK
Faculty
Consulting Fee-Pfizer, Inc. (Relationship has ended)
Grace E Linder, MD
MSK
Faculty
Nothing to disclose
Robert G Maki, MD, PhD
MSK
Faculty
Consulting Fee-Peel Therapeutics|Royalties or Patent Beneficiary-Uptodate|Stocks or stock options, excluding diversified mutual funds-Peel Therapeutics|Review Panel Member-Deciphera|Advisor-Boehringer Ingelheim Vetmedica GmbH
Anita Mamtani, MD, FACS
MSK
Faculty
Simon Mantha, MD, MPH
MSK
Faculty
Paid consultant-Johnson and Johnson (Relationship has ended)
Michael Mauro, MD
MSK
Faculty
Alison Moskowitz, MD
MSK
Faculty
Grant or research support-Seagen|Grant or research support-Merck and Company, Inc.|Grant or research support-Bristol-Myers Squibb|Grant or research support-Incyte Corporation|Grant or research support-SecuraBio|Honoraria-Seagen|Honoraria-Takeda Pharmaceuticals, Inc.|Honoraria-Merck and Company, Inc.|Honoraria-Affimed (Relationship has ended)|Grant or research support-AstraZeneca (Relationship has ended)
Robert Motzer, MD
MSK
Faculty
Consulting Fee-Merck and Company, Inc.|Consulting Fee-Exelixis (Relationship has ended)
Michael Offin, MD
MSK
Faculty
Honoraria-Jazz Pharmaceuticals (Relationship has ended)|Honoraria-Targeted Oncology (Relationship has ended)
Eileen M O'Reilly, MD
MSK
Faculty
Grant or research support-, AstraZeneca, Arcus, Elicio, Parker Institute, AstraZeneca, Pertzye|Grant or research support-BioNtech|Grant or research support-AstraZeneca|Grant or research support-Arcus Biosciences|Grant or research support-Elicio Therapeutics|Grant or research support-Digestive Care|Advisor-Merck and Company, Inc.|Advisor-AstraZeneca|Advisor-Thetis (Relationship has ended)|Advisor-Novartis AG|Advisor-BioNTech|Advisor-Bristol-Myers Squibb|Advisor-Alligator Biosciences (Relationship has ended)|Advisor-Leap Therapeutics (Relationship has ended)|Advisor-Revolution Medicine|Grant or research support-Breakthrough Cancer|Grant or research support-NCI NIH|Advisor-Tango Therapeutics|Grant or research support-Amgen|Grant or research support-Agenus|Advisor-Ikena|Advisor-Moma Therapeutics|Advisor-Regeneron (Relationship has ended)|Grant or research support-Revolution Medicine|Grant or research support-Tango Therapeutics
Michael Postow, MD
MSK
Faculty
Consulting Fee-Merck and Company, Inc. (Relationship has ended)|Grant or research support-Bristol-Myers Squibb|Grant or research support-Merck and Company, Inc.|Consulting Fee-Chugai (Relationship has ended)|Consulting Fee-Bristol-Myers Squibb (Relationship has ended)|Consulting Fee-Eisai, Inc. (Relationship has ended)|Consulting Fee-Pfizer, Inc. (Relationship has ended)|Grant or research support-Infinity|Grant or research support-Novartis AG|Grant or research support-RGenix|Consulting Fee-Erasca (Relationship has ended)|Consulting Fee-Nektar (Relationship has ended)|Consulting Fee-Replimune (Relationship has ended)
Raajit Rampal, MD, PhD
MSK
Faculty
Jessica (Stuart) Ross, MD
MSK
Faculty
Leonard B Saltz, MD
MSK
Faculty
Nothing to disclose
Rachel Sanford, MD
MSK
Faculty
Nothing to disclose
Craig S Sauter, MD
MSK
Faculty
Consulting Fee-NKARTA
Susan Seo, MD
MSK
Faculty
Nothing to disclose
Gunjan Shah , MD, MS
MSK
Faculty
Grant or research support-Johnson and Johnson|Grant or research support-Amgen|Grant or research support-Beyond Spring|Grant or research support-Bristol-Myers Squibb|Grant or research support-GPCR Therapeutics|Review Panel Member-Arcellx
Sherry Shen, MD
MSK
Faculty
Honoraria-MJH Life Sciences (Relationship has ended)|Grant or research support-Merck and Company, Inc.|Grant or research support-Sermonix Pharmaceuticals|Consulting Fee-AstraZeneca|Consulting Fee-GE Healthcare Bio-Sciences|Grant or research support-SynDevRx, Inc|Grant or research support-Novartis AG
Susan Slovin, MD, PhD
MSK
Faculty
Honoraria-Philips Medical Systems, Inc. (Relationship has ended)|Honoraria-Curio Science|Advisor-PER|Advisor-Foundation Medicine|Honoraria-APTITUDE|Advisor-Johnson and Johnson
Gerald Soff, MD
University of Miami Health System/Sylvester
Faculty
Zsofia Stadler, MD
MSK
Faculty
Eytan Stein, MD
MSK
Faculty
Advisor-PinotBio|Advisor-Janssen|Advisor-Bristol-Myers Squibb|Advisor-Agios|Advisor-Genentech, Inc.|Advisor-Abbvie|Advisor-Gilead|Consulting Fee-Syndax|Advisor-Servier|Review Panel Member-Cellectis|Honoraria-Kura (Relationship has ended)|Advisor-Daiichi Sankyo|Advisor-Syros (Relationship has ended)|Advisor-Astellas|Advisor-Debipharm (Relationship has ended)|Advisor-Janpix
Meghan C Thompson, MD
MSK
Faculty
Paid consultant-BeOne|Paid consultant-Genentech, Inc. (Relationship has ended)|Grant or research support-BeOne|Grant or research support-Genmab|Grant or research support-Abbvie|Grant or research support-Adaptive|Grant or research support-AstraZeneca|Grant or research support-Genentech, Inc.|Grant or research support-Nurix Therapeutics (Relationship has ended)|Paid consultant-Loxo Oncology at Lilly (Relationship has ended)|Other: Payment for travel and lodging, honoraria-Dava Oncology (Relationship has ended)|Paid consultant-AstraZeneca (Relationship has ended)|Paid consultant-Abbvie (Relationship has ended)|Grant or research support-Loxo Oncology at Lilly
Anna Mary Varghese, MD
MSK
Faculty
Nothing to disclose
Cy R Wilkins, MD
MSK
Faculty
Advisor-Sanofi-Aventis (Relationship has ended)|Honoraria-Techspert
Celine Yeh, MD
MSK
Faculty
Andrew D Zelenetz, MD, PhD
MSK
Faculty
Jeffrey Zwicker, MD
MSK
Faculty
Review Panel Member-CSL Behring (Relationship has ended)|Review Panel Member-Sanofi-Aventis (Relationship has ended)|Consulting Fee-Perceptive|Consulting Fee-Bioclinica (Relationship has ended)|Advisor-Regeneron|Advisor-Novartis AG|Honoraria-Incyte Corporation

Friday, March 13, 2026
Colon Cancer
9:10AM - 10:00AM
Leonard B Saltz, MD

Melanoma
10:00AM - 10:45AM
Michael Postow, MD

Prostate Cancer
10:45AM - 11:30AM
Susan Slovin, MD, PhD

Kidney Cancer
11:30AM - 12:15PM
Robert Motzer, MD

Mesothelioma
12:15PM - 1:00PM
Michael Offin, MD

Urothelial Cancer
1:15PM - 2:00PM
Gopa Iyer, MD

Testis Cancer
2:00PM - 2:45PM
Darren Feldman, MD

Uterine, Cervix, and Other Gynecologic Cancers
2:45PM - 3:30PM
Carol Aghajanian, MD

Ovarian Cancer
3:45PM - 4:30PM
Rachel Grisham, MD

Breast Cancer: Surgery
4:30PM - 5:00PM
Anita Mamtani, MD, FACS

Breast Cancer: Radiation Therapy
5:00PM - 5:30PM
Lior Braunstein, MD

Hereditary Cancer Genetics
5:30PM - 6:00PM
Zsofia Stadler, MD

Saturday, March 14, 2026
Small Cell Lung Cancer
7:00AM - 7:30AM
Jessica (Stuart) Ross, MD

HER2-Positive Breast Cancer
7:30AM - 8:20AM
Joshua Drago, MD, MS

Triple-Negative Breast Cancer
8:20AM - 9:10AM
Rachel Sanford, MD

Hormone Receptor-Positive Breast Cancer
9:10AM - 10:00AM
Sherry Shen, MD

Carcinoma of Unknown Primary
10:00AM - 10:30AM
Anna Mary Varghese, MD

Hepatocellular Cancer and Cholangiocarcinoma
10:45AM - 11:30AM
Ghassan K Abou-Alfa, MD, JD, MBA

Pancreatic and Neuroendocrine Cancers
11:30AM - 12:15PM
Eileen M O'Reilly, MD

Non-Small Cell Lung Cancer
1:00PM - 2:00PM
Kathryn C Arbour, MD

Head and Neck, Thyroid, and Non-Melanoma Skin Cancers
2:00PM - 3:00PM
Lara Dunn, MD

Anal and Rectal Cancers
3:00PM - 3:30PM
Celine Yeh, MD

Esophageal and Gastric Cancers
3:45PM - 4:30PM
David Ilson, MD, PhD

Central Nervous System Tumors
4:30PM - 5:00PM
Thomas Kaley, MD

Sarcoma
5:00PM - 5:45PM
Robert G Maki, MD, PhD

Infectious Disease
5:45PM - 6:15PM
Susan Seo, MD

Sunday, March 15, 2026
Pharmacology I_II
7:00AM - 9:00AM
Mrinal Gounder, MD

Low-Grade Non-Hodgkin Lymphoma
9:10AM - 9:50AM
Andrew D Zelenetz, MD, PhD

Chronic Lymphocytic Leukemia _Small Lymphocytic Lymphoma
9:50AM - 10:30AM
Meghan C Thompson, MD

Diffuse Large B-Cell Lymphoma _Mantle Cell Lymphoma _Burkitt Lymphoma
10:30AM - 11:30AM
Paul A Hamlin, MD

Auto _Allo
11:30AM - 12:10PM
Gunjan Shah , MD, MS

Myeloma_Amyloid
12:40PM - 1:40PM
Malin Hultcrantz, MD, PhD

Chronic Myelogenous Leukemia
1:40PM - 2:20PM
Michael Mauro, MD

Myelodysplastic
2:20PM - 2:50PM
Aaron D Goldberg, MD

Myeloproliferative Neoplasms
2:50PM - 3:30PM
Raajit Rampal, MD, PhD

Acute Myeloid Leukemia
3:45PM - 4:15PM
Eytan Stein, MD

Acute Lymphocytic Leukemia
4:15PM - 5:00PM
Mark B Geyer , MD

Hemolytic Anemia
5:00PM - 5:45PM
Gerald Soff, MD

Monday, March 16, 2026
Hodgkin Lymphoma_T Cell
8:05AM - 9:05AM
Alison Moskowitz, MD

CAR T Cell
9:05AM - 9:45AM
Craig S Sauter, MD

Thrombotic Disorders
9:45AM - 10:45AM
Jeffrey Zwicker, MD

Anticoagulation: Update on an Evolving Field
10:45AM - 11:30AM
Simon Mantha, MD, MPH

Thrombocytopenia and ITP
11:30AM - 12:00PM
Cy R Wilkins, MD

Sickle Cell Disease, Thalassemia
12:30PM - 1:15PM
Susanna Curtis, MD, PhD

Apporach to the Bleeding Patient
1:15PM - 2:00PM
Avi Leader, MD

Clinical Indications for Use of Blood Products and Associated Risks
2:00PM - 3:00PM
P. Dayand D Borge Jr., MD, PhD

Transfusion Reactions
3:00PM - 4:00PM
Grace E Linder, MD


CME Courses

Live Courses
On Demand eLearning
Coming Soon

Resources & Policies

CME Program Terms of Use
Registration Discounts
Cancellation Policy
Industry Professionals

Attendee & Faculty Information

My CME / Attendee Resources
Claim RSS Credit (MSK Staff)
Faculty Disclosure Form
Faculty Tasks Page

Connect

Locations & Visitor Info
Help / Contact Us
Subscribe to CME Announcements




MSK CME

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

©2025 Memorial Sloan Kettering Cancer Center